hotspot -WSS

hotspot

author：knowledge 2025-09-01 05:57:39 - browse：51567

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Will the market for weight loss drugs really reach $100 billion?

WSS

What don’t we know about an Alzheimer’s drug side effect?

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

The 10 drugs up first for Medicare price negotiation

Illumina names Agilent executive as new CEO

Flagship Pioneering launches a new biotech in two countries

Cigna, Humana reportedly in talks to merge

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

How to save PrEP access — and even expand it

Mayo Clinic plans $5B tech

What does generative AI mean for health care? We asked experts

What don’t we know about an Alzheimer’s drug side effect?

DIEP, the 'gold standard' of breast reconstruction, is under threat

The 10 drugs up first for Medicare price negotiation

Continuity nursing helped my family in our darkest PICU moments

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

BioMarin wins approval for gene therapy to treat hemophilia A

Cigna, Humana reportedly in talks to merge

knowledge

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Rep. Raul Ruiz on the physician shortage and more

Illumina names Agilent executive as new CEO

What American doctors can learn from their Israeli counterparts

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Amazon on where the company's health care bets are headed next

focus

leisure time

explore

hotspot